Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies-Reference-Cited by-同舟云学术

Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies

Published:2016-06 Issue:12 Volume:26 Page:2795-2800
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Xu Shengtao,Wang Guangyu,Lin Yan,Zhang Yanju,Pei Lingling,Yao Hong,Hu Mei,Qiu Yangyi,Huang Zhangjian,Zhang Yihua,Xu Jinyi

Funder

National Natural Science Foundation

China Pharmaceutical University

China Postdoctoral Science Foundation

National Innovation Experiment Program for University Students

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference22 articles.

1. The State of US Health, 1990-2010

2. Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010

3. Natural products: An evolving role in future drug discovery

4. Anticancer bioactivity of compounds from medicinal plants used in European medieval traditions

5. Synthesis and biological evaluation of novel aniline-derived asiatic acid derivatives as potential anticancer agents

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct cellular targets and anticancer mechanisms of the natural product oridonin;MedComm – Future Medicine;2023-02-24

2. Recent advances in oridonin derivatives with anticancer activity;Frontiers in Chemistry;2023-02-09

3. Syntheses and high selective cytotoxicity of dehydroabietylamine C-ring nitration derivatives;Fitoterapia;2022-09

4. Cascaded amplification of intracellular oxidative stress and reversion of multidrug resistance by nitric oxide prodrug based-supramolecular hydrogel for synergistic cancer chemotherapy;Bioactive Materials;2021-10

5. Recent progress of oridonin and its derivatives for cancer therapy and drug resistance;Medicinal Chemistry Research;2021-08-10